# Neuraptive Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuraptive-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Lafayette, US
- Website: www.neuraptive.com
- Total disclosed funding: $13M
- Latest round: Series A (Dec 18, 2018)
- Investors on record: 2

## About

Founded in 2016 and based in Colorado, US, Neuraptive Therapeutics, Inc. is a developer of products for nerve repair market use. The company's products include AxoFuse, a nerve repair system which helps patients with peripheral nerve injuries to prevent limb atrophy and nerve degeneration; AxoTrim, a surgical instrument to assist in the nerve preparation for suturing; AxoBond, secures a surgically repaired nerve during recovery, and AxoFuse to be used in clinical trials.

## Funding rounds

- Series A, Dec 18, 2018, $12M — New Rhein Healthcare Investors
- Seed, Sep 6, 2017, $1M — Central Texas Angel Network, New Rhein Healthcare Investors

## Investors

- Central Texas Angel Network — Seed
- New Rhein Healthcare Investors (https://capitalatlas.ai/funds/new-rhein-healthcare-investors) — Seed, Series A